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Abstract
Marijuana is the most frequently used illegal substance in the United States and is most
widely used among young people aged 12 to 21 years. Accurate screening and monitored
issuance of medical cannabis recommendations have been shown to decrease abuse rates
of the substance, create fewer deaths from opiates, reduce crime rates, reduce marijuana
use in youths, decrease car crash deaths, and lessen prevalence of suicide in young men.
The purpose of this project was to explore whether multiple screening methods for
depression and anxiety in patients who seek medical cannabis referrals for anxiety and
depression would improve screening and cannabis referral accuracy. A comprehensive
review of the literature was conducted, and 2 screening tools were identified. The tools
identified were the Zung self-rating anxiety scale and the Diagnostic and Statistical
Manual of Mental Disorders 5 scale. The medical director at the project site reviewed the
tools and approved them. These tools were then included in an education program for 12
staff members and providers with a pretest given to the participants prior to the staff
education program. A posttest was then administered to the same group after the staff
education program was completed and the new screening measures implemented.
Results showed that referrals for cannabis were at 85% before the 2-step screening
process was implemented; referrals for cannabis decreased to 60% with implementation
of the dual screening method, suggesting increased accuracy in screening for depression
and anxiety for cannabis referrals. This project might promote positive social change by
increasing accuracy for cannabis referrals and reducing the risk of cannabis abuse.
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Section 1: Nature of the Project
Introduction
Marijuana is identified as the most frequently used illegal substance in the United
States (Buddy, 2018). It is most widely used among young people aged 12 to 21 years
according to the 2013 National Survey on Drug Use and Health (NSDUH) (Chen, Yu,
Lasopa, & Cottler, 2017) who have lower perceptions of risk (Wall et al., 2011).
Dependence syndrome, increased risk for vehicular accidents, impaired respiratory
function, cardiovascular issues, and effects on adolescent psychosocial development and
mental health are the most probable adverse effects of regular use of marijuana (Hall &
Degenhardt, 2009).
Cannabis, or medicinal marijuana, is a therapy that has garnered much national
attention in recent years (Bridgeman & Abaiza, 2017). Controversies surrounding legal,
ethical, and societal implications associated with use, safe administration, packaging, and
dispensing; adverse health consequences and deaths attributed to marijuana intoxication;
and therapeutic indications based on limited clinical data represent some of the
complexities associated with this treatment (Bridgeman & Abaiza, 2017). Marijuana is
currently recognized by the U.S. Drug Enforcement Agency’s (DEA’s) Comprehensive
Drug Abuse Prevention and Control Act (Controlled Substances Act) of 1970 as a
Schedule I controlled substance and defined as having a high potential for abuse
(Bridgeman & Abaiza, 2017).
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The multiple implications for abuse of the substance were due to the availability
of legal cannabis (Tishler, 2015). A total of 29 states, the District of Columbia, Guam,
and Puerto Rico now allow for comprehensive public medical marijuana and cannabis
(Hasin et al., 2015). Legislation passed in California in 2004 allowed nonregistered
patients to use and possess dried marijuana and plants in quantities reasonably sufficient
to meet their current medical needs, whereas registered patients are allowed to possess 8
oz. or not more than six mature or 12 immature plants (Hoffman & Weber, 2010).
California was one of the first states to legalize medical cannabis use in 1996, allowing
Californians to possess a physician’s recommendations to acquire and use marijuana for
medical purposes (Reinarman, Nunberg, Lanthier, & Heddleston, 2011) and not be
subject to criminal penalties (Hoffman & Weber, 2010). States with medical marijuana
laws (MMLs) were seen to have higher rates of marijuana use among adolescents than
those states without MMLs (Wall et al., 2011).
For this doctoral project, I introduced change in an organization in California that
screens and issues medical cannabis recommendations to patients who use the substance
to address their depression and anxiety. Proper screening and monitored issuance of
medical cannabis recommendation has been shown to decrease abuse rate of the
substance, cause fewer deaths from opiates, reduce crime rates, reduce marijuana use in
youths, decrease car crash deaths, and lessen prevalence of suicide in young men
(Macpherson, 2015). This project is a staff and provider education program that was
developed to support the new screening methods identified from the literature.
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In Section 1, I cover the problem statement, the purpose of the project, the nature
of the project, the significance, and a summary.
Problem Statement
Cannabis was proclaimed as particularly beneficial for those with several
symptoms of psychological disorders such as depression, coping, and social anxiety
(Bonn-Miller, Boden, Bucossi, & Babson, 2013), and according to Reinarman et al.
(2011), marijuana is seen by many physicians to have substantial therapeutic uses to
address symptoms of pain, insomnia, anxiety, panic attacks, sleep disorder, appetite
issues, seizures, and involuntary movements.
Legal use of marijuana is a state-level decision and in the United States, 18 states,
and the District of Columbia, have legalized marijuana to date (National Conference of
State Legislatures, 2013). In those states, patients are allowed to use and possess small
quantities of marijuana for medical purposes (Hoffman & Weber, 2010). However, in
2012, an estimated 74% of adolescents in the United States had used someone else’s
medical cannabis (Salomonsen-Sautel, Sakai, Thurstone, Corley, & Hopfer, 2012), which
resulted in adverse effects such as addiction, intoxication, and disturbance in cognitive
and motor function due to the abuse of the substance (Volkow, Baler, Compton, & Weiss,
2014). Medical intervention and hospitalization to address the adverse effects will result
in increase in health care costs (Rapp, 2015).
Despite the legalization of marijuana in many states, it is categorized as a
“Schedule 1 controlled substance,” a classification that necessitates nurses to acquire the
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best understanding of the substance as well as the particular laws in the state where they
practice (Volkow et al., 2014). An increased need exists for deep understanding
especially because more and more people in the United States demand for use of medical
cannabis (Volkow et al., 2014). Awareness of the substance and its effects, policies
covering the use of cannabis for medical purposes, and actively taking part in the
screening of patients who need medical cannabis recommendation will enable nurse
practitioners to perform one of their significant roles which is to save the health care
industry from spending too much of its funds (Rapp, 2015).
Physicians in my target organization issue recommendations for medical cannabis
based on the Compassionate Use Act of 1996 (saclaw.org, 2017) after confirming
through a screening process that patients are qualified. The organization has been using
one screening method and I have personally witnessed first-time and subsequent-visit
patients who have been denied of medical cannabis recommendations. As a DNPprepared practitioner, I learned from the site that there was a need for identification of
alternative methods or more than one screening method so patients will not have the
opportunity to manipulate the screening process on their subsequent visits. Furthermore,
multiple screening methods are available as researchers have conducted studies on
various screening tools to ensure that the appropriate screening is used to identify those
who are eligible for medical cannabis recommendation and to decrease the prevalence of
the abuse of the said substance (Committee on Substance Abuse, 2011).
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Purpose
This doctoral project was guided by the following practice-focused questions:


What evidence supports the use of screening methods for patients suffering from
depression and anxiety and seeking medical cannabis recommendation?



What are the results of a staff education on alternative screening methods for
determination of the need for cannabis referrals in the western United States?
When managing patients who use medical marijuana, de Vries and Green (2012)
listed five key points the APN must be aware of:



Be well-informed about current research regarding all pharmaceuticals.



Educate patients on the physical and psychological effects of medical marijuana, and how
to interact with legally prescribed medications.



Document medical marijuana use as reported by the patient as well as reported effects.



Educate the patient on state and federal penalties regarding medical marijuana.



Do not supply, fund, obtain, or in any other way prepare medical marijuana for patient
consumption.
Therapeutic cannabis use raises a number of dilemmas for nurses (de Vries &
Green, 2012). They are caught in the middle as marijuana has been declared legal in
some states while the U.S. DEA declares that the substance has no medical use and has a
high chance for abuse (Volkow et al., 2014). In addition, although they are aware of the
adverse effects of marijuana, nurses need to have a deeper understanding of the screening
for medical cannabis to avoid potential abuse (Volkow et al., 2014). This planned project
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is also aimed at addressing that gap-in nursing practice by providing a staff education
program developed to educate nursing staff and providers on the alternative methods for
screening.
The introduction of change in the target organization through the use of more than
one screening method was aimed to ensure appropriate screening, provision of precise
treatment, reduce adolescent access to diverted medical marijuana, and decrease health
care costs. My role in this project was to identify alternate screening tools through a
search of the literature and I provided staff education on the topic and the instruments
identified.
Nature of the Doctoral Project
The target organization is a medical clinic in Orange County, California, which
caters requests for medical cannabis recommendations. Through formal discussions with
and approvals from the organization’s leaders, this project identified alternative screening
processes, provided the foundations for a significant practice change for screening
patients who request medical cannabis, and used the AGREE II tool that evaluated the
alternative instruments that are selected for their effectiveness for implementation at the
site.
The target population for the staff education was the staff of the medical clinic.
Data was gathered within the organization and were the actual results of assessments and
screening procedures done by the clinic’s primary Physician and medical assistant.
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Significance
The clinic’s physicians, nurses, medical manager, and administrative staff are the
main stakeholders of this project. Their active participation in this endeavor was
significant to achieve the goal of making significant contributions to the health care
industry and in promoting positive social change. Moreover, appropriate screening should
ensure that medical cannabis recommendations are only provided to qualified patients to
avoid further adolescent access to diverted medical marijuana and to decrease substance
abuse rates (Salomonsen-Sautel et al., 2012), decrease health care costs (Lizeretti &
Extremera, 2011), and help improve the lives of the target population.
The success of this doctoral project may prove to be beneficial in mental health
services where abuse of medications was identified (National Institute of Mental Health,
2016).
Summary
All state regulations consent patients to use and acquire small amounts of
marijuana for medical use (Hoffman & Weber, 2010). As health care providers, we must
ensure that abuse does not take place and patients are assisted to optimum health
(Hoffman & Weber, 2010). As an advanced-practice nurse, I acknowledge that status quo
is no longer applicable in today’s health care system and have the capability of promoting
efficient policy development.
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In the following sections of this doctoral project, I address the appropriate model
that guided this endeavor. Furthermore, I discuss its relevance to nursing practice and
provide the significance of my role as a DNP student.
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Section 2: Background and Context
Introduction
Cannabis is the preferred medical term for marijuana or cannabis (Lee, 2012). In
this study, I use the terms marijuana and cannabis interchangeably. Bonn-Miller et al.
(2013) posited that cannabis is particularly beneficial for those with several symptoms of
psychological disorders such as depression, coping, and social anxiety. Marijuana is
perceived by many physicians to have substantial therapeutic benefits to address (not
only) symptoms of pain, insomnia, sleep disorders, appetite issues, seizures, and
involuntary movements but also of anxiety and panic attacks (Reinarman et al., 2011).
California was one of the first states to legalize medical cannabis use in 1996,
allowing Californians to possess physician’s recommendations to acquire and use
marijuana for medical purposes (Reinarman et al., 2011) and not be subject to criminal
penalties (Hoffman & Weber, 2010). Legislation passed in California in 2004 allowed
nonregistered patients to use and possess dried marijuana and plants in quantities
reasonable enough to meet their current medical needs; registered patients are allowed to
possess 8 oz. or not more than six mature or 12 immature plants (Hoffman & Weber,
2010). Although the California law placed restrictions on the legal use of the drug, abuses
still have occurred. Providers who prescribed cannabis did not consistently know if the
patient continued to need the drug. Therefore, a screening process was implemented.
Proper screening and monitored issuance of medical cannabis recommendations
resulted in a decreased abuse rate of the substance, caused fewer deaths from opiates,
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reduced crime rates, reduced marijuana used in youths, decreased car crash deaths, and
lessened prevalence of suicide in young men (Macpherson, 2015). However, an estimated
74% of adolescents in the United States had used someone else’s medical cannabis
(Salomonsen-Sautel et al., 2012), which resulted in adverse effects such as addiction,
intoxication, and disturbance in cognitive and motor function due to the abuse of the
substance (Volkow et al., 2014). Cannabis abuse is costly in terms of medical
interventions and hospitalizations to address the adverse effects of cannabis abuse
affecting not only hospital costs, but costs to the families and patients who use it when
the need no longer exists (Rapp, 2015).
Physicians in my target organization issue recommendations for medical cannabis
based on the Compassionate Use Act of 1996 (saclaw.org, 2017) after confirming
through a screening process that patients are qualified. The organization has been using
one-screening method. With only one-screening method, patients may become familiar
with the screening tool and know how to answer the questions to assure they will be
provided a renewal of their cannabis recommendation. For this reason, alternative
methods of screening are needed.
As a DNP-prepared practitioner, I recognized the necessity to work on this project
and presented the relevance of using other screening methods or more than one-screening
method so patients will not have the opportunity to anticipate the required answers to the
screening process on their subsequent visits. The Committee on Substance Abuse (2011)
discussed that studies have been conducted on various screening tools to ensure that the
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appropriate screening is used to identify those who are eligible for medical cannabis
recommendation and to decrease the prevalence of the abuse of the substance.
My aim in this project was to introduce a practice change in the local clinical
organization through the recommendation of more than one screening method to ensure
appropriate screening, provision of precise treatment to decrease substance abuse rates
(Salomonsen-Sautel et al., 2012), decrease health care costs (Lizeretti & Extremera,
2011), and help improve the lives of the target population and this changed will be
initiated through staff education.
The following practice-focused questions guided this doctoral project:


What evidence supports the use of screening methods for patients suffering from
depression and anxiety and seeking medical cannabis recommendation?



What are the results of a staff education on alternative screening methods for
determination of the need for cannabis referrals in the western United States?
Section 2 covered the concepts, models, & theories, relevance to nursing practice,
local background and context, and the role of the DNP student.
Concepts, Models, and Theories
Nurses are urged to use up-to-date research evidence to deliver the best possible
care (LoBiondo-Wood, Haber, Berry, & Yost, 2013). Research-based practice has better
patient outcomes than routine, procedural nursing care and informs nursing decisions,
actions and interactions with patients (Doody and Doody, 2011). Evidence-based practice
involves the use of reliable, explicit and judicious evidence to make decisions about the
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care of individual patients combining the results of well-designed research, clinical
expertise, patient concerns, and patient preferences (Kueny, Sheyer, Lehan Mackin, &
Titler, 2015).
The Iowa Model of Evidence-Based Practice to Promote Quality Care focuses on
organization and collaboration incorporating conduct and use of research, along with
other types of evidence (Titler et al., 2001). This model helped to focus on knowledgeand problem-focused triggers, leading to question current nursing practices and whether
care can be improved through the use of current research findings (Melnyk & FineoutOverholt, 2011).
Using the Iowa Model of Evidence-Based Practice to Promote Quality Care
involves taking seven essential steps, as follows:
Step 1: Selection of a Topic
Medical cannabis was chosen as the center of this project because of the priority
and magnitude of the problem, its application to all areas of practice, its contribution to
improving care, the availability of data and evidence in the problem area, the
multidisciplinary nature of the problem, and the commitment of staff (Doody & Doody,
2011).
Step 2: Forming a Team
The team is responsible for development, implementation, and evaluation
(LoBiondo-Wood et al., 2013). The composition of the team should be directed by the
chosen project and include all interested stakeholders (Doody & Doody, 2011). In
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creating a team for this project, the team should draw up written policies, procedures and
guidelines that are evidence-based (LoBiondo-Wood et al., 2013). The medical team may
perceive task performance as a more justifiable use of time than seeking evidence for
action or designing guidelines for existing practice (Kueny et al., 2015). For this project, I
will invite physicians, medical assistants, and nurses from the organization and will
review the process of the Iowa model steps with them.
Step 3: Evidence Retrieval
Evidence was made up of the screening tools gathered from the literature as part
of my research. The evidence was obtained by using key search terms and the designated
databases for the search were EBSCO Publishing, CINAHL, Medline, Elsevier, –
Institute for Healthcare Improvement (ihi.org/), and National Institutes of Health
(nih.gov/) and I referenced materials from 2014-2018
Step 4: Grading the Evidence
In this project, I presented and used at least two screening tools on top of the tool
that the target organization is currently using and the evidence that supports each one. I
will grade the evidence using the effectiveness criteria which will relate to whether the
intervention achieves the intended outcomes (Doody & Doody, 2011). This evidence will
be presented to the project team.
Step 5: Developing an Evidence-Based Practice Standard
Team members conform to agree on recommendations for practice after a critique
of the literature (Doody & Doody, 2011). Medical marijuana in evidence-based practice

14
is ideally a patient-centered approach, which when implemented, is highly individualized
(LoBiondo-Wood et al., 2013). In this project, I will set up a time for the team to meet to
go review the materials I have collected and to discuss the merits of each. As a group, at
least two alternative strategies for screening will be selected.
Step 6: Implementing Evidence-Based Practice
LoBiondo-Wood et al. (2013) discussed that features such as written policies,
procedures, and guidelines that are evidence-based need to be considered for
implementations to take place. Social and organizational factors can influence
implementation and support placed on the integration of evidence into practice is
essential (Kueny et al., 2015). For this project, I will develop the policy for the use of the
selected screening tools and will ask the project team to provide feedback on the content
and the timeline for implementation.
Step 7: Evaluation
This is a significant phase that will assess the value and contribution of the
evidence into practice (Doody & Doody, 2011). Audit and feedback through the process
of implementation should be conducted (Ivers et al., 2012) and success will not be
achieved without support from frontline leaders and the organization (Moon & Kim
2015). For this phase I will develop evaluation tools for use by the site after
implementation and will provide education classes to the multidisciplinary staff at the
site.
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Relevance to Nursing Practice
Despite the legalization of marijuana in many states, cannabis is categorized as a
“Schedule 1 controlled substance,” a classification that necessitates nurses to acquire the
best understanding of the substance as well as the particular laws in the state where they
practice (Volkow et al., 2014). An increased need exists for deep understanding
especially because more people in the United States of patients who need medical
cannabis recommendation will enable nurse practitioners to perform one of their
significant roles, which is to save the health care industry from spending too much of its
funds (Rapp, 2015). This is a significant role, but it was not my main focus in this
project. The priority was on saving lives and to educate nurses on how to avoid abuse by
screening first for the need for the drug.
Therapeutic cannabis use raises a number of dilemmas for nurses (de Vries &
Green, 2012). They are caught in the middle as marijuana has been declared legal in
some states, while the U.S. DEA declares that the substance has no medical use and has a
high chance for abuse (Volkow et al., 2014). Furthermore, although they are aware of the
adverse effects of marijuana, nurses need to have a deeper understanding of the screening
for medical cannabis to avoid potential abuse (Volkow et al., 2014). This planned project
was also aimed at addressing that gap-in nursing practice.
Local Background and Context
The target organization is a clinic that performs screening methods to identify
patients who need medical cannabis to address their anxiety and depression issues.
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During the completion of my practicum hours in the said clinic, although not directly
interacting with the patients, I was allowed to collaborate with the medical assistant and
observe the screening process. I have seen patients who were denied of medical cannabis
recommendation. Those denied of the recommendation were those who came in “high”
and smelled of marijuana and manifested loud and aggressive behavior. After undergoing
the screening process, both the physician and the medical assistant agreed that they need
cannabis only for recreation purposes.
The clinic is located in the state of California where medical cannabis use was
legalized in 1996 allowing Californians to possess physician's recommendations to
acquire and use marijuana for medical purposes (Reinarman et al., 2011) and not be
charged with criminal penalties (Hoffman & Weber, 2010).
Role of the DNP Student
In compliance to the practicum requirement of this DNP program, I had the
opportunity to render practicum services in a clinic that screens patients for medical
cannabis recommendation. My critical thinking as a medical professional was stimulated
after close observation of the screening process and seeing the possibility of the process
being manipulated. As a medical practitioner in a state where the use of cannabis has
been declared legal, I believed in the urgency to make a noteworthy contribution that will
cause the decrease of the abuse of the substance.
This project, therefore, becomes not only a compliance to the DNP program
requirement, but my contribution to the betterment of the lives of the locals or the people
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at the target community. My roles were mostly related, but not limited to, the gathering of
evidence, formation of a project team, staff education, completion of this project, and the
dissemination of information.
Role of the Project Team
For this project, I worked closely with a project team, which was made up of the
head physician, medical assistant, and nurses at the medical clinic that screens patients
for medical cannabis recommendation. After presenting the potential screening tools,
evidence was graded and then presented to the team. The project team was granted
appropriate time to review the materials and decided on at least two alternative strategies
and provided feedback on the content and the timeline for the implementation.
Summary
The Iowa Model of Evidence-Based Practice to Promote Quality Care discussed
in this section provided the efficient guide to the identification and grading of the
evidence which was presented to the team. The identification of the relevance of the
project to nursing practice is another key point of this section. It should provide an
efficient transition to the succeeding section where the evidence generated will be
analyzed and synthesized and enable the provision of the connection of the gap in
practice.

18
Section 3: Collection and Analysis of Evidence
Introduction
Cannabis was proclaimed as particularly beneficial for those with several
symptoms of psychological disorders such as depression, coping, and social anxiety
(Bonn-Miller et al., 2013), and according to Reinarman et al. (2011), marijuana is seen by
many physicians to have substantial therapeutic uses to address symptoms of pain,
insomnia, anxiety, panic attacks, sleep disorder, appetite issues, seizures, and involuntary
movements.
Legal use of marijuana is a state-level decision and in the United States, 18 states
and the District of Columbia have legalized marijuana (National Conference of State
Legislatures, 2013). In those states, patients are allowed to use and possess small
quantities of marijuana for medical purposes (Hoffman & Weber, 2010). However, an
estimated 74% of adolescents in the U.S. had used someone else's medical cannabis
(Salomonsen-Sautel et al., 2012) which resulted in adverse effects such as addiction,
intoxication, and disturbance in cognitive and motor function due to the abuse of the
substance (Volkow et al., 2014). Medical intervention and hospitalization to address the
adverse effects will result in increase in health care costs (Rapp, 2015).
Despite the legalization of marijuana in many states, it is still categorized as a
“Schedule 1 controlled substance”, a classification that necessitates nurses to acquire the
best understanding of the substance as well as the particular laws in the state where they
practice (Volkow et al., 2014). There is an increased need for deep understanding
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especially because more and more people in the U.S. demand for use of medical cannabis
(Volkow et al., 2014). Awareness of the substance and its effects, policies covering the
use of cannabis for medical purposes, and actively taking part in the screening of patients
who need medical cannabis recommendation will enable nurse practitioners to perform
one of their significant roles which is to save the health care industry from spending too
much of its funds (Rapp, 2015).
Physicians in my target organization issue recommendations for medical cannabis
based on the Compassionate Use Act of 1996 (saclaw.org, 2017) after confirming
through a screening process that patients are qualified. The organization has been using
one screening method and I have personally witnessed first-time and subsequent-visit
patients who have been denied of medical cannabis recommendations. As a DNPprepared practitioner, I found the necessity to exercise my critical thinking and worked
on this project and presented the relevance of using more than one screening methods so
patients will not have the opportunity to manipulate the screening process on their
subsequent visits. Multiple screening methods have been developed and tested and are
available for use in primary care setting (Committee on Substance Abuse, 2011).
Research conducted on various screening tools helps to validate screening tools as a
mean to identify patients whose condition makes them eligible for medical cannabis
recommendation and to decrease the prevalence of cannabis abuse (Committee on
Substance Abuse, 2011).
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The target organization where this project took place is a clinic that performs
screening methods to identify patients who need medical cannabis to address their
anxiety and depression issues. On admission to the organization, patients were screened
initially then on subsequent visits went swiftly through the screening phase when the
medical assistant employed the same screening tool used in their initial visit, the online
screening tool of the Anxiety and Depression Association (ADAA) for Generalized
Anxiety Disorder (GAD), which the ADAA developed from the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (ADAA, 2018) is used
at the location. In discussing the screening process with the medical assistant my theory
was confirmed in patients on subsequent visits quickly completed the form indicating
they were familiar with the screening method proposed the use of the Zung self-rating
anxiety scale (Zung SAS) as an alternate screening method. The Zung SAS is a 20-item
self-assessment designed to quantify a patient’s level of anxiety (Dunstan, Scott, & Todd,
2017). As a part of their mission and goals, the medical team at the organization aims to
improve the lives of the locals by making significant contribution in the decreased rate of
substance abuse by ensuring that medical cannabis recommendations are granted only to
those who need it for medical purposes by implementing other screening tools. The staff
did not have the knowledge or skills for alternate screening methods and therefore my
project focused on searching the literature to identify alternate screening tools, then
educating the staff on their use. My role in this project was to identify alternate screening
tools for use at the site.
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In Section 3, I cover the practice-focused questions, sources of evidence,
published outcomes and research, archival and operational data, evidence generated for
the doctoral project, and the analysis and synthesis of information.
Practice-Focused Questions
This doctoral project was guided by the following practice-focused questions:


What evidence supports the use of screening methods for patients suffering from
depression and anxiety and seeking medical cannabis recommendation?



What are the results of a staff education on alternative screening methods for
determination of the need for cannabis referrals in the western United States?
Therapeutic cannabis use raises a number of dilemmas for nurses (de Vries &
Green, 2012). They are caught in the middle as marijuana has been declared legal in
some states while the U.S. DEA declares that the substance has no medical use and has a
high chance for abuse (Volkow et al., 2014). Although nurses are aware of the adverse
effects of marijuana, nurses need to have a deeper understanding of the screening for
medical cannabis to avoid potential abuse (Volkow et al., 2014). This lack of knowledge
of medical cannabis represents the gap in practice that I addressed in this project.
The introduction of staff education on alternative screening tools to prepare the
organization for a change in the use of more than one screening method was aimed to
ensure appropriate screening, provision of precise treatment, reduce adolescent access to
diverted medical marijuana, and decrease health care costs.
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Sources of Evidence
When managing patients who use medical marijuana, de Vries and Green (2012)
listed five key points for the APN:


Be well-informed about current research regarding all pharmaceuticals.



Educate patients on the physical and psychological effects of medical marijuana, and how
to interact with legally prescribed medications.



Document medical marijuana use as reported by the patient as well as reported effects.



Educate the patient on state and federal penalties regarding medical marijuana.



Do not supply, fund, obtain, or in any other way prepare medical marijuana for patient
consumption.
Evidence were gathered from the target organization on the current processes for
screening. I completed a literature search, identified alternate screening methods, and
then a staff education program was developed and presented to the staff at the site. The
education program included the evidence obtained from the literature search to support
the screening tools, educational procedure for use with patients, and steps for how and
when to alternate the use of the tools. Results were measured through pretests and
posttests that helped determine the outcome of alternative screening methods for
determination of the need for cannabis referrals in the western United States.
Published Outcomes and Research
Databases and Search Engines
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The literature review was conducted using databases from CINAHL, Medline,
and other sources including Elsevier, Institute for Healthcare Improvement (ihi.org/), and
National Institutes of Health (nih.gov/).
Search Terms
Listed are the terms used to search for references to address the concerns raised in
my practice-focused questions: medical cannabis, screening for medical cannabis
patient, patients seeking medical cannabis recommendation, medicinal marijuana,
marijuana, cannabis, and medicinal marijuana study. Inclusion criteria were articles
published between 2013 and 2018, peer reviewed, and published in the English language.
Inclusion in the education were nurses and providers who work in the clinic in a large
western state.
Marijuana is identified as the most frequently used illegal substance in the United
States (Buddy, 2018). Cannabis was proclaimed as particularly beneficial for those with
several symptoms of psychological disorders such as depression, coping, and social
anxiety (Bonn-Miller et al., 2013). Therapeutic cannabis use raises a number of dilemmas
for nurses, the cannabis used is usually obtained illegally, which can have consequences
for both those who use it and nurses who provide treatment in the community. (de Vries
& Green, 2012).
Appropriate screening should ensure that medical cannabis recommendations are
only provided to qualified patients to avoid further adolescent access to diverted medical
marijuana and to decrease substance abuse rates (Salomonsen-Sautel et al., 2012).
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Although medical marijuana is used to address some indications such as depression and
anxiety, the medical staff should be efficiently educated on the proper screening for
medical cannabis recommendation to ensure that it is appropriately used and the
recipients of the recommendations will benefit from its use (Hill, 2015) and to reduce the
frequent and heavy recreational use to evade the increasing levels of cannabis abuse (Hall
& Degenhardt, 2009).
Archival and Operational Data
Nurses are urged to use up-to-date research evidence to deliver the best possible
care (LoBiondo-Wood et al., 2013). Research-based practice has better patient outcomes
than routine, procedural nursing care and informs nursing decisions, actions and
interactions with patients (Doody and Doody, 2011). Evidence-based practice involves
the use of reliable, explicit and judicious evidence to make decisions about the care of
individual patients combining the results of well-designed research, clinical expertise,
patient concerns and patient preferences (Kueny et al., 2015).
The providers at the site make their referrals after each screening process;
although use of new instruments will be welcomed by the staff, the need for education on
how to use the new tools and when and how to rotate their use was the rationale for this
education project.
Evidence Generated for the Doctoral Project
The Iowa model of Evidence-Based Practice to Promote Quality Care focuses on
organization and collaboration incorporating conduct and use of research, along with
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other types of evidence (Melnyk & Fineout-Overholt, 2011). This model helped me to
focus on knowledge- and problem-focused triggers, leading to question current nursing
practices and whether care can be improved through the use of current research findings
(Melnyk & Fineout-Overholt, 2011).
Participants
The participants for this project were the staff and the providers. I developed and
provided the education for them using the screening tools that I identified from the
literature. I provided them with an anonymous consent to participate in the education
project. I asked them to complete a pretest, sit through an hour-long education program,
and complete a post-test on the content that I provided.
Procedure
Employing the Iowa Model of Evidence-Based Practice to Promote Quality Care
involves taking seven (7) essential steps, as follows:
Step 1: Selection of a Topic
Medical cannabis was chosen as the center of this project because of the priority
and magnitude of the problem, its application to all areas of practice, its contribution to
improving care, the availability of data and evidence in the problem area, the
multidisciplinary nature of the problem, and the commitment of staff (Doody & Doody,
2011).
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Step 2: Forming a Team
The team, which is composed of the staff and the providers, will review the
evidence and tools that I will identify, the education program and policy that I will
develop. I will come up with a form that they can fill out so I can get feedback from each
of the expert panel or team and use that information to improve my education program
for the staff.
Step 3: Evidence Retrieval
The education program was based on the evidence from the screening tools
gathered from the literature.
Step 4: Grading the Evidence
In this project, I presented and employed at least two screening tools on top of the
tool that the target organization is currently using and the evidence that supports each
one. I will grade the evidence using the effectiveness criteria which will relate to whether
the intervention achieves the intended outcomes (Doody & Doody, 2011). This evidence
will be presented to the project team.
Step 5: Developing an Evidence-Based Practice Standard
Team members conform to agree on recommendations for practice after a critique
of the literature (Doody & Doody, 2011). Medical marijuana in evidence-based practice
is ideally a patient-centered approach, which when implemented, is highly individualized
(LoBiondo-Wood et al., 2013). In this project, I will set up a time for the team to meet to
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go review the materials I have collected and to discuss the merits of each. As a group, at
least 2 alternative strategies for screening will be selected.
Step 6: Implementing Evidence-Based Practice
LoBiondo-Wood et al. (2013) discussed that features such as written policies,
procedures, and guidelines that are evidence-based need to be considered in order for
implementations to take place. Social and organizational factors can influence
implementation and support placed on the integration of evidence into practice is
essential (Kueny et al., 2015). For this project I developed the policy for the selected
screening tools and asked the project team to provide feedback on the content and the
timeline for implementation.
Step 7: Evaluation
This is a significant phase that assessed the value and contribution of the evidence
(Doody & Doody, 2011). Audit and feedback through the process of implementation will
be conducted by the site after this project is completed (Ivers et al., 2012) and success
will not be achieved without support from frontline leaders and the organization (Moon
& Kim 2015). I evaluated the results of the education presentation with a posttest on the
content presented in the education program. The site will be responsible for completing
the final evaluation of the implementation as that will take place after this developmental
stage is completed.

28
Protection
Cannabis, or medicinal marijuana, is a therapy that has garnered much national
attention in recent years. (Bridgeman & Abaiza, 2017). Controversies surrounding legal,
ethical, and societal implications associated with use, safe administration, packaging, and
dispensing; adverse health consequences and deaths attributed to marijuana intoxication;
and therapeutic indications based on limited clinical data represent some of the
complexities associated with this treatment. (Bridgeman & Abaiza, 2017). Marijuana is
currently recognized by the U.S. DEA’s Comprehensive Drug Abuse Prevention and
Control Act (Controlled Substances Act) of 1970 as a Schedule I controlled substance
and defined as having a high potential for abuse (Bridgeman & Abaiza, 2017).
Institutional Review Board approval was obtained and no data collections or analysis
occurred until approval has been received. The IRB approval number for the project was
03-26-19-0725261. Further, to assure protections of the participants of the education
program, no personal identification was obtained from the participants and the pretest and
posttest questionnaires had unique identifiers.
Analyzing and Synthesis
I have always been in close contact with the clinic manager even when I was not
permitted to directly interact with the patients. Efficient collaboration with the clinic
manager provided access and permission to gather, track, record, and organize the
evidence and to present the education program. The participants were the staff and the
providers at the clinic. A pretest was administered to them before the education program.
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Each participant had two copies of the test that had the same unique ID for the pre- and
post-test. After completion of the pretest, the test was placed in an envelope. I obtained
the envelope before administering the education program. After the education program
was completed, I asked the participants to complete the post-test. The post-tests were
placed in the envelope with the pretests and I collected them without knowing which test
was provided by any participant.
Pretest and posttest scores were then entered into an Excel spreadsheet and
compared against each other. The number of the participants and their individual roles in
the clinic were reviewed. Results of the pretest and posttest contents were compared.
Summary
Evidence to support the education program and the screening tools that were used
were the result of the literature review. Data from the pretests and posttests were
provided by the staff before and after the education program was given. This section
provides the detail for the plan for the project.
The succeeding section is aimed to educate the readers of the gap-in-practice and
the purpose of this doctoral project; sources of evidence and how they were obtained are
discussed; findings and implications to positive social change are provided; and proposed
solutions that will address the gap-in-practice are described.
In Section 4, I work with findings, implications, recommendations, contribution
of the project team, and the strengths and limitations of the project.

30
Section 4: Findings and Recommendations
Introduction
Cannabis was proclaimed as particularly beneficial for those with several
symptoms of psychological disorders such as depression, coping, and social anxiety
(Bonn-Miller et al., 2013), and according to Reinarman et al. (2011), marijuana is seen by
many physicians to have substantial therapeutic uses to address symptoms of pain,
insomnia, anxiety, panic attacks, sleep disorder, appetite issues, seizures, and involuntary
movements.
Despite the legalization of marijuana in many states, it is still categorized as a
“Schedule 1 controlled substance,” a classification that necessitates nurses to acquire the
best understanding of the substance as well as the particular laws in the state where they
practice (Volkow et al., 2014). An increased need exists for deep understanding
especially because more and more people in the U.S. demand for use of medical cannabis
(Volkow et al., 2014). Awareness of the substance and its effects, policies covering the
use of cannabis for medical purposes, and actively taking part in the screening of patients
who need medical cannabis recommendation will enable nurse practitioners to perform
one of their significant roles which is to save the health care industry from spending too
much of its funds (Rapp, 2015).
Physicians in my target organization issue recommendations for medical cannabis
based on the Compassionate Use Act of 1996 (saclaw.org, 2017) after confirming
through a screening process that patients are qualified. The organization has been using
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one screening method and I have personally witnessed first-time and subsequent-visit
patients who have been denied of medical cannabis recommendations. As a DNPprepared practitioner, I saw the necessity to exercise my critical thinking, worked on this
project and presented the relevance of using other screening methods or more than one
screening method so patients will not have the opportunity to manipulate the screening
process on their subsequent visits. More important, the providers at the organization did
express that they saw the need for alternate methods as they do have patients who come
for second visits or refills.
This planned project was also aimed at addressing that gap-in nursing practice by
providing a staff education program developed to educate nursing staff and providers on
the alternative methods for screening. The introduction of change in the target
organization through the use of more than one screening method via staff education
program was aimed to ensure appropriate screening, provision of precise treatment,
reduce adolescent access to diverted medical marijuana, and decrease health care costs.
My role in this project was to identify alternate screening tools through a search of the
literature and provide staff education on the topic and the instruments identified.
Evidence were provided by the target organization on their current processes for
screening. Literature search and study were done to identify alternate screening methods.
Pre- and Post-tests were administered to the staff at the organization to identify the
significance of using more than one screening methods on patients seeking medical
cannabis recommendation.
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This doctoral project was guided by the following practice-focused questions:
The project focused-question Number 1 was: What evidence supports the use of
screening methods for patients suffering from depression and anxiety and seeking
medical cannabis recommendation?
Screening tools must be used on patients seeking medical cannabis
recommendation (Caulkins, Kilmer, & Kleiman, 2016). Health care providers must be
sure of the need of the patients and these screening tools will help them identify the need
(Caulkins, Kilmer, & Kleiman, 2016). Caulkins, Kilmer, and Kleiman (2016) further
discussed that screening methods serve as guide for health care providers in identifying
which ones can and do manipulate systems; thus, ensure that only those who are truly
qualified of the recommendations may acquire them.
To answer project-focused question Number 1, I conducted a literature search to
identify the most current evidence available on screening tools for cannabis referrals.
Thorough literature search was done on Walden library, CINAHL, Medline, Elsevier,
Institute for Healthcare Improvement, and the National Institutes of Health which are
reliable sources. These sites provided information that indicated authorized groups or
individuals who stand behind the information they present. The dates of research are also
given which guide readers to identify that the information presented are recent enough to
meet the requirement of the paper or project.
In one of the meetings with the decision-makers of the organization, I was given
the opportunity to present the two alternate screening methods:
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Zung Self-Rating Anxiety Scale (Zung SAS) (See Appendix A).



Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) (wee
Appendix B) with Instructions to Clinicians (See Appendix C).

The Zung Self-Rating Anxiety Scale (Zung SAS) was designed by W. K. Zung, MD, to
quantify a patient's level of anxiety. It is a 20-item self-assessment scored on a Likerttype scale of 1-4 ("a little of the time," "some of the time," "a good part of the time," and
"most of the time") (Biggs, Wylie, and Ziegler, 1978). ZUNG (SAS) is free and available
online and was built to assess levels of anxiety based on cognitive, autonomic, motor, and
central nervous systems manifestations. The final assessment is derived from the total
score which ranges from 20 to 80. The raw score has an Anxiety Index which is used to
identify a patient's level of anxiety: 20 to 44, normal range; 45 to 59, mild to moderate
anxiety level; 60 to 74, marked to severe anxiety level; and 75 to 80, extreme anxiety
level (Biggs, Wylie, & Ziegler, 1978).
DSM-5, which stands for the Diagnostic and Statistical Manual of Mental
Disorders 5, is the result of more than a decade’s effort by mental health experts. The
latest versions are available online and may be accessed for free. This test stipulates the
definition and classification of mental disorders to provide advancement in diagnoses,
treatment, and research. DSM has screening tests for specific disorders and ages, with
instructions for physicians, scoring, and interpretation (American Psychiatric
Association, 2013).
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The project-focused question Number 2 was: What are the results of a staff
education on alternative screening methods for determination of the need for cannabis
referrals in the western United States?
To answer project question Number 2, I prepared the pretest (See Appendix D)
and posttest (See Appendix E) as well as the staff education program which was created
after the completion of the literature review and after the screening tools that were
qualified for use were decided upon.
The staff benefited from the staff education program as they are made aware and
reminded of other screening tools which were results of thorough research. Gaining
knowledge on alternate screening methods helped the staff and the organization identify
and understand varying behaviors of patients seeking medical cannabis. The ability to
identify and assess said behaviors will make it possible to avoid manipulation of the
system; therefore, medical cannabis recommendations will be given only to those who
truly need them.
Findings and Implications
Procedures
The participants were given a pre-test before the suggested additional screening
tools were taught in the education program. The education program on the screening tool
was discussed during the staff education held within the organization’s premises. The
pre-tests results were kept in individual envelopes assigned to each participant using a
unique identifier and no personal information were collected.
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There were patients on subsequent visits and went swiftly through the screening
phase when the medical assistant employed the same screening tool they have been using
which is the online screening tool of the Anxiety and Depression Association (ADAA)
for Generalized Anxiety Disorder (GAD) which ADAA developed from the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (ADAA, 2018).
The medical assistant supported my theory from observation that patients on succeeding
visits may manipulate the existing screening method which they have become familiar
with; thus he discussed my suggestion of using another screening tool which is the Zung
Self-Rating Anxiety Scale (Zung SAS), a 20-item self-assessment designed to quantify a
patient’s level of anxiety.
After the head physician’s approval and after implementing both the ADAA for
GAD and the Zung SAS screening tools, some patients were indeed found to not needing
the drug anymore. As a part of their mission and goals, the medical team at the
organization aims to improve the lives of the locals by making significant contribution in
the decreased rate of substance abuse by ensuring that medical cannabis
recommendations are granted only to those who need it for medical purposes by
implementing other screening tools.
The staff education program was then given to the participants and afterwards the
post-test questions were administered. Post-tests were given to the participants after the
education was completed. Post-tests were secured in the same individual envelopes with
unique IDs and then all were gathered for analysis.
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Results
Demographics of participants. The 12 participants are medical practitioners with at least
a bachelor’s degree. Made up of 4 males and 8 females, the team had been working
together for at least three years in screening patients for medical cannabis
recommendation (Table 1).
Table 1
Demographics
Gender
Number of years with
the organization
Number of years involvement
in screening process

Male
(33%)
5 years
(58%)
5 years
(58%)

Female
(67%)
3.8 years average
(42%)
3.8 years average
(42%)

Table 2
Pretest Results
How many screening tools implemented
Have screened patients on subsequent visits
Do you submit reports with recommendations after
each screening?
Part of the team that makes final decision on the
releasing of medical cannabis recommendations
Percentage of patients being issued with medical
cannabis after using one screening tool
Based on 85% average of patients being given
medical cannabis recommendations, would you
recommend using another screening tool?
Based on reports with recommendations (by the
other members of the screening team), what is the
% of recommendations for medical cannabis?

100% replied : 1
100% replied : YES
100% replied : YES
75% - YES

25% - NO

Average 85%
100% replied: YES

Average 85%
67% said patients are swift in
answering the screening test;
33% said patients are impatient,
anxious to be done immediately
with the screening process
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Pretest Results
Results showed that the participants were familiar with implementing one
screening tool during the screening process but were not aware of the need for more than
one screening tool to test for the need for a cannabis referral. All participants indicated
that the one screening tool was sufficient when answering the questions on the pretest
indicating a lack of knowledge about options for more than one screening tool or of the
rationale for the use of more than one screening tool.
Table 3
Posttest Results
Beneficiary of staff education program
How many screening tools used for this week?
Have screened patients on subsequent visits
Do you submit reports with recommendations after
each screening?
Part of the team that makes final decision on the
releasing of medical cannabis recommendations
Percentage of patients being issued with medical
cannabis after using one screening tool
Based on 60% average of patients being given
medical cannabis recommendations, would you
recommend using another screening tool?
Based on reports with recommendations (by the
other members of the screening team), what is the
% of recommendations for medical cannabis?

100% replied: YES
100% replied: 2
75% - YES
25% - NO
100% replied: YES
75% - YES

25% - NO
Average 60%

100% replied: YES

Average 60%
80% said patients seemed restless due to
unfamiliarity of the tools
20% said patients are anxious to be done
immediately with the screening process

Posttest Results
After the scheduled staff education (See Appendix F), the staff of the organization
underwent education on the additional screening tools and then post-tests were given to
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them. Post-tests were secured in individual envelopes and then were gathered for
analysis. Post-tests showed how the participants gained knowledge from staff education
and how they are able to differentiate screening process results using one screening tool
from results using at least two screening tools. All of the participants who were part of
the team that makes the final decision on the releasing of medical cannabis
recommendation expressed that they noticed differences in decisions and
recommendations when two screening tools were used.
Recommendations
After the post-test, the manager, along with the clinic’s primary physician, called
for a team meeting to discuss the result. I presented to them the fact that the post-test
showed that all of the members of the team that make the final decision on the releasing
of medical cannabis recommendation expressed that they noticed differences in decisions
and recommendations when two screening tools were used in the process. Prior to using
two screening tools, the team approved 85% of requests for medical cannabis
recommendations (see Table 1). However, after using two alternate screening tools, the
team saw the need to approve 60% of requests for medical cannabis recommendations.
The team agreed that it is best to use two screening tools during the screening process.
The recommendation for screening included continued use of the current tool (Anxiety
and Depression Association (ADAA) for Generalized Anxiety Disorder (GAD)) and pair
it with either of the two suggested tools which are Zung-SAS and DSM-5. The team
agreed to use pairs alternately. Thus, Zung-SAS and DSM-5 for patients on subsequent
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visits, and ADAA for GAD and pair it with either Zung-SAS or DSM-5 for first-time
patients.
Contribution of the Doctoral Project Team
The project team was made up of the Manager, Head Physician, Medical
Assistants, and Nurses at the medical clinic that screens patients for medical cannabis
recommendation. After presenting the potential screening tools, evidence was graded and
then presented to the team. The project team was granted appropriate time to review the
materials and decide on at least two alternative strategies and provided feedback on the
content and the timeline for the implementation.
Strengths and Limitations of the Project
The most important aspect of this project is the fact that the decision makers of
the organization understood the benefits and agreed to the use of the alternate screening
tools presented. Also, with the head of the organization being an efficient and respected
leader and being open to change, the staff education program went along very smoothly.
The rest of the team were submissive to the activities and were cooperative in both the
pre- and post-tests.
Although the project focuses on a small organization which results in a small
sample size, I don’t see this as a project limitation. At this point, the size may not be an
issue. What is significant is the result or the response of the team involved.
While I believe that I have done thorough literature reading and study on the
subject, I noticed lack of previous research studies on the topic of the significance of
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using pre-screening tools when performing assessment on patients seeking medical
cannabis recommendations.
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Section 5: Dissemination Plan
Dissemination Plan
At this point in my project, I am confident that I have clearly described the
problem in practice in my target organization and that there was a possibility of giving
medical cannabis recommendations to patients who did not need it. Also, they have been
using only one screening tool, which made it easier for patients on subsequent visits to go
through the screening process and acquire medical cannabis recommendations.
The organization where I aimed to do the staff education program was
considerably small in size. Therefore, gathering of the significant participants and
dissemination was not difficult to achieve. The manager made arrangements so that I was
able to do my PowerPoint presentation in the clinic’s conference room with the entire
staff/human power on the day that they are closed for business.
The manager also pointed out the significance of the availability of the primary
physicians and other members of the team that makes the final decision in who receives
the medical cannabis recommendation. The staff education program on the alternate
screening tools would be beneficial not only in outpatient clinics such as the target
organization, but also in other inpatient health care facilities.
The dissemination plan included the discussion of the alternate screening tools
and the results of the pre- and post-tests where majority of the participants and/or project
team members agreed that it is best to use two more alternate screening tools on top of
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the one which is currently being used. The manager requested electronic copies of the
dissemination saved in various files and computers in their organization.
Analysis of Self
Seeing the reality of patients getting medical cannabis recommendations when
they don’t need it motivated me to aim to educate medical practitioners and remind them
of other screening tools that have been tested through research. As an advanced-practice
nurse, I decided that staff education will work best to increase the knowledge among the
health care providers involved in the screening process of patients seeking medical
cannabis recommendation. Through years of practice, I have seen how lack of knowledge
will not only hurt patients but the health care industry as well.
As a DNP-prepared practitioner, my aim was to educate colleagues of the
existence of evidence-based and user-friendly screening tools that will address the issue
of patients becoming too familiar with the existing tools and manipulate them. As a
medical professional motivated to be an effective agent of change, I made sure my
project was focused on improving not only my project skills but most importantly the
patient outcomes.
Within the completion of the project, I was able to efficiently initiate the staff
education program, successfully complete it, and I have further honed my project skills.
Therefore, I am able to move forward with my long-term professional goals such as to
put more effort in staff education and be more active in quality improvement ventures
that will reinforce evidence-based practice and improved patient outcomes.
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Summary
As an advanced-practice nurse, I believe that status quo is no longer applicable in
today’s health care structure and that I should move forward and aim to be more capable
in promoting efficient policy development. In my attempt to effectively introduce change
and ensure positive patient outcomes, I collaborated with the health care providers in the
target organization and did a thorough literature study. These efforts resulted in efficient
and successful initiation and completion of staff education program where the
beneficiaries were reminded of other screening tools which have been used and tested
through research.
I may not have implemented the planned change but I am confident that I was
able to make a noteworthy contribution as I was able to communicate the guidelines to
the organization’s leaders and policymakers; and these guidelines may be used by their
organization to address the rate of substance abuse which is one of the leading health
problems in the United States (Bonn-Miller et al., 2013).
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